IBT offers investors the opportunity to invest in the growing biotechnology sector, which is creating innovative medicines that treat unmet medical needs and have the potential to produce very attractive long term returns. In the years to 31 August 2013 the NASDAQ Biotechnology Index NBI a representative index for the biotech sector outperformed the S&P 500 by 100 .
IBT offers investors the opportunity to invest in the growing biotechnology sector, which is creating innovative medicines that treat unmet medical needs and have the potential to produce very attractive long term returns. In the years to 31 August 2013 the NASDAQ Biotechnology Index NBI a representative index for the biotech sector outperformed the S&P 500 by 100 .